设计,合成和生物评估海洋纳夫托基-纳夫托衍生物作为潜在的抗癌剂
Yujuan Li1, Luyou Yelv1, Xiaoqiu Wu1
1Department of Chemistry, College of Food Science and Technology, Shanghai Ocean University, Shanghai, China.
Journal of enzyme inhibition and medicinal chemistry
|October 15, 2024
概括
一种新型的纳夫托基诺-纳夫托衍生物,化合物13,通过诱导细胞亡和抑制细胞增殖,显示出强大的抗癌活性. 这种化合物向EGFR/PI3K/Akt通路,表明其作为一种新的癌症治疗的潜力.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 海洋真菌产生具有细胞毒性潜力的二次代谢物,如化合物5.
- 对纳夫托基-纳夫托衍生物的抗癌作用和机制的理解有限.
- 需要新的抗癌药物,针对各种癌症细胞系.
研究的目的:
- 设计,合成和评估用于抗癌活性的新型纳夫托基诺-纳夫托衍生物.
- 识别有力的衍生品并阐明它们的生物作用机制.
- 研究13化合物对癌细胞增殖和亡的影响.
主要方法:
- 新型纳夫托基-纳夫托衍生物的合成.
- 在实验室对HCT116,PC9和A549癌细胞系进行抗癌活性评估.
- 通过切割的caspase-3和Bcl-2蛋白质表达的亡诱导分析.
- 西部斑点分析以评估EGFR/PI3K/Akt信号通路.
主要成果:
- 化合物13对HCT116,PC9和A549细胞表现出显著的细胞毒性作用,与化合物5相比,IC50值得到改善.
- 化合物13诱导显著的亡,通过调高分裂的caspase-3和调低Bcl-2.
- 化合物13通过降低EGFR/PI3K/Akt信号通路的调节来抑制癌细胞的增殖.
结论:
- 新型纳夫托基-纳夫托衍生物显示出有前途的抗癌性质.
- 化合物13是一种强大的抗癌剂,具有有利的作用机制.
- 化合物13代表了癌症治疗的潜在治疗.
相关概念视频
Structure-Activity Relationships and Drug Design
668
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
668
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
151
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
151
Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K


